Literature DB >> 19058581

Compliance with hepatitis B and hepatitis C virus infection screening among HIV-1 infected patients in a resource-limited setting.

Somnuek Sungkanuparph1, Pawinee Wongprasit, Weerawat Manosuthi, Kalayanee Atamasirikul.   

Abstract

Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are important risk factors for mortality among HIV-infected patients. We assessed compliance with screening for HBV and HCV infection prior to initiation of ART in a resource-limited setting. Six hundred thirty-eight patients with a mean age of 38.4 years (53% males) were studied. Prior to initiation of antiretroviral therapy (ART) 371 patients (58%) were screened for HBV and 273 (43%) were screened for HCV infection. Of those screened, 9.7% had HBV infection and 8.8% had HCV infection. Given the relatively high prevalence of HBV and HCV infection among HIV-infected patients, screening for HBV and HCV infections prior to ART initiation should not be omitted in the resource-limited setting.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19058581

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  5 in total

1.  Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort.

Authors:  Nimzing Gwamzhi Ladep; Patricia Aladi Agaba; Oche Agbaji; Auwal Muazu; Placid Ugoagwu; Godwin Imade; Graham Cooke; Sheena McCormack; Simon David Taylor-Robinson; John Idoko; Phyllis Kanki
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

2.  Seroprevalence of Hepatitis B and Hepatitis C virus infection among HIV infected patients in Mumbai.

Authors:  Sandhya Sawant; Sachee Agrawal; Jayanthi Shastri
Journal:  Indian J Sex Transm Dis AIDS       Date:  2010-07

3.  Challenges in Providing Treatment and Care for Viral Hepatitis among Individuals Co-Infected with HIV in Resource-Limited Settings.

Authors:  Wirach Maek-A-Nantawat; Anchalee Avihingsanon; Pirapon June Ohata
Journal:  AIDS Res Treat       Date:  2012-03-26

4.  Long-term hepatitis B virus (HBV) response to lamivudine-containing highly active antiretroviral therapy in HIV-HBV co-infected patients in Thailand.

Authors:  Woottichai Khamduang; Catherine Gaudy-Graffin; Nicole Ngo-Giang-Huong; Gonzague Jourdain; Alain Moreau; Nuananong Luekamlung; Guttiga Halue; Yuwadee Buranawanitchakorn; Sura Kunkongkapan; Sudanee Buranabanjasatean; Marc Lallemant; Wasna Sirirungsi; Alain Goudeau
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

5.  Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival.

Authors:  Marcelo Chen; Wing-Wai Wong; Matthew G Law; Sasisopin Kiertiburanakul; Evy Yunihastuti; Tuti Parwati Merati; Poh Lian Lim; Romanee Chaiwarith; Praphan Phanuphak; Man Po Lee; Nagalingeswaran Kumarasamy; Vonthanak Saphonn; Rossana Ditangco; Benedict L H Sim; Kinh Van Nguyen; Sanjay Pujari; Adeeba Kamarulzaman; Fujie Zhang; Thuy Thanh Pham; Jun Yong Choi; Shinichi Oka; Pacharee Kantipong; Mahiran Mustafa; Winai Ratanasuwan; Nicolas Durier; Yi-Ming Arthur Chen
Journal:  PLoS One       Date:  2016-03-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.